Special Edition on Utility Measurement, PharmacoEconomics
Pharmacoeconomics
.
2017 Dec;35(Suppl 1):5-6.
doi: 10.1007/s40273-017-0542-0.
Author
Andrew Lloyd
1
Affiliation
1
Acaster Lloyd Consulting Ltd, London, UK. andrew.lloyd@acasterlloyd.com.
PMID:
29052155
DOI:
10.1007/s40273-017-0542-0
No abstract available
Publication types
Editorial
MeSH terms
Cost-Benefit Analysis
Economics, Pharmaceutical*
Health Status
Humans
Outcome Assessment, Health Care / methods*